MALVERN, Pa., April 19, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) OCGN, a biotechnology company focused on…
BOSTON, April 18, 2024 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on providing innovative medical therapies that…
Thursday, Enliven Therapeutics Inc ELVN released proof of concept data from the Phase 1 clinical trial evaluating ELVN-001 in patients with chronic…
Primary Results from SEQUOIA-HCM to Elaborate on Positive Topline Results in Patients with Obstructive Hypertrophic Cardiomyopathy Two Additional Analyses from…
Unfortunately, an increase in early-onset pancreatic cancer has garnered significant media attention lately. From 2010-2019, gastrointestinal cancer rates jumped almost…
SOUTH SAN FRANCISCO, Calif., April 05, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated CYTK today announced additional 48-week data from FOREST-HCM…
SOUTH SAN FRANCISCO, Calif., April 05, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated CYTK today announced additional 48-week data from FOREST-HCM…
Partners Beckley Psytech and atai Life Sciences ATAI have jointly announced positive initial results from a Phase 2a study of…
On March 20, Congressional leaders at both the House and Senate Appropriations Committees released new spending legislation that would continue…
Monday, AstraZeneca Plc AZN released latest analysis of the results from the DUO-E Phase 3 trial of Imfinzi (durvalumab) plus platinum-based chemotherapy followed by…